Skip to main content
Erschienen in: Cardiovascular Toxicology 3/2017

19.07.2016

Flecainide Toxicity: A Case Report and Systematic Review of its Electrocardiographic Patterns and Management

verfasst von: Michael A. Valentino, Andrew Panakos, Loheetha Ragupathi, Janna Williams, Behzad B. Pavri

Erschienen in: Cardiovascular Toxicology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

In the setting of flecainide toxicity, supraventricular tachycardia can manifest as a bizarre right or left bundle branch block, sometimes with a northwest axis, and can easily be mistaken for ventricular tachycardia leading to inappropriate therapy. We conducted a comprehensive literature review for cases of flecainide toxicity. We found 21 articles of flecainide toxicity in adult patients in which 22 ECG tracings were published. In patients with flecainide toxicity and QRS duration ≤ 200 ms, the ECGs were more likely to show RBBB, visible P waves (p = 0.03), and shorter QT (p = 0.02) and QTc intervals (p = 0.004). With QRS duration > 200 ms, the ECGs were more likely to show LBBB, loss of P waves, a northwest axis (p = 0.01), and longer QT and QTc intervals. Deaths were reported only in patients with QRS duration >200 ms, and the outcome of death or requirement for mechanical circulatory support was more prevalent in patients with a QRS duration > 200 ms [2/13 (15.4 %) vs. 6/10 (60 %), p = 0.04]. In patients with access to the medication, flecainide toxicity should be suspected with: (1) broad QRS, (2) RBBB morphology with QRS ≤ 200 ms; RBBB or LBBB morphology with QRS ≥ 200 ms (3) HR out of proportion to the degree of hemodynamic instability. The duration of the QRS interval is prognostic, with mortality and the requirement for mechanical circulatory support being more common in patients with a QRS > 200 ms.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cleveland, J. C., Cigarroa, J. E., et al. (2014). 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology, 64(21), 2246–2280.CrossRef January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cleveland, J. C., Cigarroa, J. E., et al. (2014). 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology, 64(21), 2246–2280.CrossRef
2.
Zurück zum Zitat Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., et al. (2012). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. European Heart Journal, 33(21), 2719–2747.CrossRefPubMed Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., et al. (2012). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. European Heart Journal, 33(21), 2719–2747.CrossRefPubMed
3.
Zurück zum Zitat Blomström-Lundqvist, C., Scheinman, M. M., Aliot, E. M., Alpert, J. S., Calkins, H., Camm, A. J., et al. (2003). ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology. Circulation, 108(15), 1871–1909.CrossRefPubMed Blomström-Lundqvist, C., Scheinman, M. M., Aliot, E. M., Alpert, J. S., Calkins, H., Camm, A. J., et al. (2003). ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology. Circulation, 108(15), 1871–1909.CrossRefPubMed
4.
Zurück zum Zitat Winkelmann, B. R., & Leinberger, H. (1987). Life-threatening flecainide toxicity. A pharmacodynamic approach. Annals of Internal Medicine, 106(6), 807–814.CrossRefPubMed Winkelmann, B. R., & Leinberger, H. (1987). Life-threatening flecainide toxicity. A pharmacodynamic approach. Annals of Internal Medicine, 106(6), 807–814.CrossRefPubMed
5.
Zurück zum Zitat Devin, R., Garrett, P., & Anstey, C. (2007). Managing cardiovascular collapse in severe flecainide overdose without recourse to extracorporeal therapy. Emergency Medicine Australasia, 19(2), 155–159.CrossRefPubMed Devin, R., Garrett, P., & Anstey, C. (2007). Managing cardiovascular collapse in severe flecainide overdose without recourse to extracorporeal therapy. Emergency Medicine Australasia, 19(2), 155–159.CrossRefPubMed
6.
Zurück zum Zitat Köppel, C., Oberdisse, U., & Heinemeyer, G. (2008). Clinical course and outcome in class IC antiarrhythmic overdose. Journal of Toxicology - Clinical Toxicology, 28(4), 433–444.CrossRef Köppel, C., Oberdisse, U., & Heinemeyer, G. (2008). Clinical course and outcome in class IC antiarrhythmic overdose. Journal of Toxicology - Clinical Toxicology, 28(4), 433–444.CrossRef
7.
Zurück zum Zitat Crijns, H. J., van Gelder, I. C., & Lie, K. I. (1988). Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment. American Journal of Cardiology, 62(17), 1303–1306.CrossRefPubMed Crijns, H. J., van Gelder, I. C., & Lie, K. I. (1988). Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment. American Journal of Cardiology, 62(17), 1303–1306.CrossRefPubMed
8.
Zurück zum Zitat Courand, P.-Y. N., Sibellas, F., Ranc, S., Mullier, A., Kirkorian, G., & Bonnefoy, E. (2013). Arrhythmogenic effect of flecainide toxicity. Cardiology Journal, 20(2), 203–205.CrossRefPubMed Courand, P.-Y. N., Sibellas, F., Ranc, S., Mullier, A., Kirkorian, G., & Bonnefoy, E. (2013). Arrhythmogenic effect of flecainide toxicity. Cardiology Journal, 20(2), 203–205.CrossRefPubMed
9.
Zurück zum Zitat Bou-Abboud, E., & Nattel, S. (1996). Relative role of alkalosis and sodium ions in reversal of class I antiarrhythmic drug induced sodium channel blockade by sodium bicarbonate. Circulation, 94(8), 1954–1961.CrossRefPubMed Bou-Abboud, E., & Nattel, S. (1996). Relative role of alkalosis and sodium ions in reversal of class I antiarrhythmic drug induced sodium channel blockade by sodium bicarbonate. Circulation, 94(8), 1954–1961.CrossRefPubMed
10.
Zurück zum Zitat Weinberg, G. L., VadeBoncouer, T., Ramaraju, G. A., Garcia-Amaro, M. F., & Cwik, M. J. (1998). Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology, 88(4), 1071–1075.CrossRefPubMed Weinberg, G. L., VadeBoncouer, T., Ramaraju, G. A., Garcia-Amaro, M. F., & Cwik, M. J. (1998). Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology, 88(4), 1071–1075.CrossRefPubMed
11.
Zurück zum Zitat Litonius, E. (2012). Treatment of acute intoxication with intravenous lipid emulsion: animal and human studies. Helsinki: University of Helsinki. Litonius, E. (2012). Treatment of acute intoxication with intravenous lipid emulsion: animal and human studies. Helsinki: University of Helsinki.
12.
Zurück zum Zitat Ellsworth, H., Stellpflug, S. J., Cole, J. B., Dolan, J. A., & Harris, C. R. (2013). A life-threatening flecainide overdose treated with intravenous fat emulsion. Pacing and Clinical Electrophysiology, 36(3), e87–e89.CrossRefPubMed Ellsworth, H., Stellpflug, S. J., Cole, J. B., Dolan, J. A., & Harris, C. R. (2013). A life-threatening flecainide overdose treated with intravenous fat emulsion. Pacing and Clinical Electrophysiology, 36(3), e87–e89.CrossRefPubMed
13.
Zurück zum Zitat Sivalingam, S. K., Gadiraju, V. T., Hariharan, M. V., Atreya, A. R., Flack, J. E., & Aziz, H. (2013). Flecainide toxicity—Treatment with intravenous fat emulsion and extra corporeal life support. Acute Cardiac Care, 15(4), 90–92.CrossRefPubMed Sivalingam, S. K., Gadiraju, V. T., Hariharan, M. V., Atreya, A. R., Flack, J. E., & Aziz, H. (2013). Flecainide toxicity—Treatment with intravenous fat emulsion and extra corporeal life support. Acute Cardiac Care, 15(4), 90–92.CrossRefPubMed
Metadaten
Titel
Flecainide Toxicity: A Case Report and Systematic Review of its Electrocardiographic Patterns and Management
verfasst von
Michael A. Valentino
Andrew Panakos
Loheetha Ragupathi
Janna Williams
Behzad B. Pavri
Publikationsdatum
19.07.2016
Verlag
Springer US
Erschienen in
Cardiovascular Toxicology / Ausgabe 3/2017
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-016-9380-0

Weitere Artikel der Ausgabe 3/2017

Cardiovascular Toxicology 3/2017 Zur Ausgabe